Literature DB >> 16934075

Face-to-face interviewing in predonation screening: lack of effect on detected human immunodeficiency virus and hepatitis C virus infections.

Sheila F O'Brien1, Wenli Fan, Shefali S Ram, Mindy Goldman, Rama C Nair, Jo Anne Chiavetta, Eleftherios C Vamvakas.   

Abstract

BACKGROUND: Predonation screening has become more elaborate over the years, while human immunodeficiency virus (HIV)- and hepatitis C virus (HCV)-positive donations have declined. The impact of face-to-face interviewing and of the format of the Donor Health Assessment Questionnaire (DHAQ) have not been evaluated. STUDY DESIGN AND METHODS: Canadian Blood Services DHAQ records between 1990 and 2004 were examined, and changes in them were tracked. The proportion of first-time donors permanently deferred for HIV or HCV risk, and the HIV and HCV rates per 100,000 donations, were calculated annually. Time-series analysis was used to determine whether major predonation screening changes had any effect on the HIV or HCV rates or permanent deferrals.
RESULTS: In 1992, receiving money or drugs for sex was added to the DHAQ; otherwise, the content of high-risk questions changed little between 1990 and 2004. In 1997, the method of administration of the DHAQ changed from donor-completed to face-to-face interviewing for high-risk questions. Permanent deferrals for HIV or HCV risk factors and HIV and HCV rates in first-time donors decreased over this period. The HIV rates were close to 0 before 1997, whereas HCV rates decreased steadily through 2004. There was no interruption in rates in 1997 when the method of administration changed.
CONCLUSION: Face-to-face interviewing for high-risk questions had no effect on HIV or HCV rates in first-time donations over 15 years of observation (during the latter 8 of which face-to-face interviewing was in place), and it did not increase permanent deferrals for HIV or HCV risk factors.

Entities:  

Mesh:

Year:  2006        PMID: 16934075     DOI: 10.1111/j.1537-2995.2006.00906.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Number of recent sexual partners among blood donors in Brazil: associations with donor demographics, donation characteristics, and infectious disease markers.

Authors:  Giuseppina Maria Patavino; Cesar de Almeida-Neto; Jing Liu; David J Wright; Alfredo Mendrone-Junior; Maria Inês Lopes Ferreira; Anna Bárbara de Freitas Carneiro; Brian Custer; João Eduardo Ferreira; Michael P Busch; Ester Cerdeira Sabino
Journal:  Transfusion       Date:  2011-07-14       Impact factor: 3.157

2.  Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors.

Authors:  Claude Tayou Tagny; Maxime Diané Kouao; Hamane Touré; Jalel Gargouri; Ahamada Said Fazul; Siaka Ouattara; Ludovic Anani; Habiba Othmani; Lochina Feteke; Honorine Dahourou; Guy Olivier Mbensa; Simplice Molé; Yacouba Nébié; Madeleine Mbangue; Michel Toukam; Mahommed Ould Boulahi; Lalatiana Valisoa Andriambelo; Olivat Rakoto; Mounirou Baby; Rakia Yahaya; Amelia Bokilo; Florent Senyana; Dora Mbanya; Caroline Shiboski; Edward L Murphy; Jean Jacques Lefrère
Journal:  Transfusion       Date:  2011-10-20       Impact factor: 3.157

3.  Implementation of a script for predonation interviews: impact on human immunodeficiency virus risk in South African blood donors.

Authors:  Josephine Mitchel; Brian Custer; Zhanna Kaidarova; Edward L Murphy; Karin van den Berg
Journal:  Transfusion       Date:  2019-04-04       Impact factor: 3.157

Review 4.  Selecting the Right Donors - Still a Challenge: Development of a Uniform Donor Questionnaire in Germany.

Authors:  Ruth Offergeld; Margarethe Heiden
Journal:  Transfus Med Hemother       Date:  2017-07-18       Impact factor: 3.747

Review 5.  Surveillance of transfusion-transmissible infections comparison of systems in five developed countries.

Authors:  Sheila F O'Brien; Shimian Zou; Syria Laperche; Lisa J Brant; Clive R Seed; Steven H Kleinman
Journal:  Transfus Med Rev       Date:  2011-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.